Literature DB >> 34190571

Aspergillus terreus Species Complex.

Cornelia Lass-Flörl1, Anna-Maria Dietl1, Dimitrios P Kontoyiannis2, Matthias Brock3.   

Abstract

Infections due to Aspergillus species are an acute threat to human health; members of the Aspergillus section Fumigati are the most frequently occurring agents, but depending on the local epidemiology, representatives of section Terrei or section Flavi are the second or third most important. Aspergillus terreus species complex is of great interest, as it is usually amphotericin B resistant and displays notable differences in immune interactions in comparison to Aspergillus fumigatus. The latest epidemiological surveys show an increased incidence of A. terreus as well as an expanding clinical spectrum (chronic infections) and new groups of at-risk patients being affected. Hallmarks of these non-Aspergillus fumigatus invasive mold infections are high potential for tissue invasion, dissemination, and possible morbidity due to mycotoxin production. We seek to review the microbiology, epidemiology, and pathogenesis of A. terreus species complex, address clinical characteristics, and highlight the underlying mechanisms of amphotericin B resistance. Selected topics will contrast key elements of A. terreus with A. fumigatus. We provide a comprehensive resource for clinicians dealing with fungal infections and researchers working on A. terreus pathogenesis, aiming to bridge the emerging translational knowledge and future therapeutic challenges on this opportunistic pathogen.

Entities:  

Keywords:  Aspergillus terreus; accessory conidia; aleurioconidia; amphotericin B; antifungal agents; diagnosis; epidemiology; fungal infections; in vitro resistance; in vivo resistance

Mesh:

Substances:

Year:  2021        PMID: 34190571      PMCID: PMC8404697          DOI: 10.1128/CMR.00311-20

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   50.129


  5 in total

1.  Echinocandins and Their Activity against Aspergillus terreus Species Complex: a Novel Agar Screening Method.

Authors:  Nina Lackner; Roya Vahedi-Shahandashti; Sonja Jähnig; Lea Schönherr; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2021-12-13       Impact factor: 5.938

Review 2.  Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India.

Authors:  Valliappan Muthu; Ritesh Agarwal; Atul Patel; Soundappan Kathirvel; Ooriapadickal Cherian Abraham; Ashutosh Nath Aggarwal; Amanjit Bal; Ashu Seith Bhalla; Prashant N Chhajed; Dhruva Chaudhry; Mandeep Garg; Randeep Guleria; Ram Gopal Krishnan; Arvind Kumar; Uma Maheshwari; Ravindra Mehta; Anant Mohan; Alok Nath; Dharmesh Patel; Shivaprakash Mandya Rudramurthy; Puneet Saxena; Nandini Sethuraman; Tanu Singhal; Rajeev Soman; Balamugesh Thangakunam; George M Varghese; Arunaloke Chakrabarti
Journal:  Lancet Infect Dis       Date:  2022-04-04       Impact factor: 71.421

3.  COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility.

Authors:  Nina Lackner; Claudius Thomé; Dietmar Öfner; Michael Joannidis; Timo Mayerhöfer; Rohit Arora; Eldina Samardzic; Wilfried Posch; Robert Breitkopf; Cornelia Lass-Flörl
Journal:  J Fungi (Basel)       Date:  2022-01-18

4.  Aspergillus terreus and the Interplay with Amphotericin B: from Resistance to Tolerance?

Authors:  Roya Vahedi-Shahandashti; Anna-Maria Dietl; Ulrike Binder; Markus Nagl; Reinhard Würzner; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2022-03-07       Impact factor: 5.938

5.  Characterization of Aspergillus terreus Accessory Conidia and Their Interactions With Murine Macrophages.

Authors:  Isabell Henß; Christoph Kleinemeier; Lea Strobel; Matthias Brock; Jürgen Löffler; Frank Ebel
Journal:  Front Microbiol       Date:  2022-06-16       Impact factor: 6.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.